UNSPSC 51161560: Nisbuterol

This classification denotes an anti-asthmatic agent with the molecular formula C22H27NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NKL13V61JH, chemically known as [2-acetyloxy-4-[2-(tert-butylamino)-1-hydroxyethyl]phenyl]4-methoxybenzoate but generally known as nisbuterol, which bears US NIH Compound Identifier 3047793. European Medicines Agency schedules nisbuterol its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09305MIG. Most nations schedule nisbuterol under HS 29225000 and SITC 51467.

As of Q4 2014, NISBUTEROL remains the US FDA Preferred Term for this commodity. Nisbuterol bears US NLM identifiers UMLS ID C2983896 and NCI Concept Code C90819. SMILES: CC(=O)OC1=C(C=CC(=C1)C(CNC(C)(C)C)O)OC(=O)C2=CC=C(C=C2)OC.

UNSPSC 51161560 Nisbuterol is a Commodity code for a specific bronchodilator pharmaceutical used in respiratory treatment. State and local governments procure nisbuterol primarily through health departments, correctional facilities, emergency medical services agencies, and public hospital systems for inpatient and outpatient respiratory management. The product is typically sourced as a finished pharmaceutical ready for clinical administration, often as part of formulary procurement or emergency stock replenishment for acute-care settings. Issuing bodies span state health and human services departments, county correction and detention facilities, municipal emergency services divisions, and independent hospital districts.

The source provided contains no recent state or local contract opportunities tagged to this code. Without posted solicitations or awarded contracts in the <most-recent-state-local-contract-opportunities> block, no representative geographic spread, issuing-body activity pattern, or recent RFP/RFQ/IFB/ITB notice can be characterized. The code shows no actionable procurement signal at this time.